
    
      Intravitreal injection of 1.25 mg of ziv aflibercept was done in different retinal diseases
      including myopic CVN,resistant diabetic macular edema to previous ranibizumab injection and
      non ischaemic CRVO .Thorough ophthalmic evaluation was done including BCVA(best corrected
      visual acuity) ,anterior and posterior segment examination ,fundus fluorescein angiography
      and OCT(optical coherence tomography) were performed for all patients .Injection was repeated
      as PRN(pro re nata) method after one month if persistent intraretinal or subretinal fluid was
      found.
    
  